6
Views
0
CrossRef citations to date
0
Altmetric
Anticancers, Hormonals & Metabolic Disease Therapy

Patent Evaluation: Linolenic Acid Formulations for the Treatment of Premenstrual Syndrome

Pages 2000-2002 | Published online: 02 Mar 2011
 

Summary

Novelty: A dietary treatment of the symptoms of pubertal premenstrual syndrome (PMS) is disclosed, comprising linolenic acids, calcium and iron sources, and optionally magnesium, vitamin B6 and other vitamins. The linolenic acids are thought to promote prostaglandin synthesis, hence alleviating PMS; the other constituents are present to replace excess losses during the pubertal period.

Biology: A small clinical trial comprising pubescent females took an exemplified formulation of the claim daily for two months, and are stated to have shown improvements in daily energy, PMS symptoms and skin condition. However, no specific data are provided.

Chemistry: Linolenic acid is provided as the native acid (Merck Index 5383) and/or as γ-linolenic acid (Merck Index 5384) at about 0.1 mg/day in the form of Evening Primrose or Borage oils. Calcium is presented as the gluconate, carbonate or dicalcium phosphate; iron as ferrous sulphate, gluconate or fumarate. Example formulations are provided, incorporating the diverse constituents at their recommended daily intake levels or below.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.